Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -203.37M | -205.45M | -183.87M | -96.03M | -126.78M |
| Total Depreciation and Amortization | 17.42M | 17.13M | 16.88M | 16.61M | 16.39M |
| Total Amortization of Deferred Charges | 1.92M | 1.97M | 1.94M | 2.09M | 2.08M |
| Total Other Non-Cash Items | 198.06M | 200.91M | 201.49M | 113.34M | 111.38M |
| Change in Net Operating Assets | -22.82M | -4.84M | -22.50M | -11.78M | 3.22M |
| Cash from Operations | -8.79M | 9.72M | 13.94M | 24.23M | 6.29M |
| Capital Expenditure | -16.33M | -17.48M | -17.74M | -19.23M | -21.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.19M | 69.91M | 8.50M | -4.25M | -23.72M |
| Cash from Investing | 92.86M | 52.43M | -9.24M | -23.48M | -45.08M |
| Total Debt Issued | 0.00 | 0.00 | 9.40M | 316.25M | 316.25M |
| Total Debt Repaid | -40.76M | -40.76M | 0.00 | -246.12M | -246.12M |
| Issuance of Common Stock | 3.35M | 3.35M | 2.30M | 2.30M | 2.62M |
| Repurchase of Common Stock | -6.26M | -9.21M | -12.21M | -39.03M | -39.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -9.40M | -25.03M | -25.03M |
| Cash from Financing | -43.67M | -46.62M | -9.91M | 8.37M | 8.68M |
| Foreign Exchange rate Adjustments | 2.51M | 881.00K | -201.00K | 1.26M | -470.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.91M | 16.42M | -5.41M | 10.37M | -30.57M |